COMMUNIQUÉ DE PRESSE
News
-
-
-
COMMUNIQUÉ DE PRESSE
NANOBIOTIX présentera sa vision pour révolutionner la conception et le développement de médicaments à travers sa prochaine plateforme nanothérapeutique le 19 décembre 2024
Nanobiotix présente sa plateforme nanothérapeutique lors d'un événement virtuel le 19/12 à 15h00 CET / 9h00 ET pour améliorer les traitements pour les patients atteints de cancer -
COMMUNIQUÉ DE PRESSE
NANOBIOTIX to Introduce Vision for Transforming Drug Design and Development with Next Nanotherapeutic Platform on 19 December 2024
Nanobiotix announces virtual event 'Accelerating the Future of Nanotherapeutics' on December 19, 2024, showcasing Curadigm Nanoprimer Platform for drug development -
COMMUNIQUÉ DE PRESSE
Applied DNA Announces Fourth Quarter and Fiscal Year 2024 Financial Results, Announces Strategic Restructuring to Prioritize the Manufacture of Critical Starting Materials for Genetic Medicines
Applied DNA Sciences, Inc. reports financial results for Q4 FY2024 and announces strategic restructuring with focus on genetic medicines. Completes GMP manufacturing facility by Jan 9, 2025 -
-
-
-
COMMUNIQUÉ DE PRESSE
PillSafe Founders' Interview Featured on Bloomberg, Fox Business, and Nasdaq
Interview featuring Dr. John Barr and Jim Patton discussing PillSafe Technologies' role in securing prescriptions and fighting the opioid crisis. Founders share insights on innovative pill delivery system -
COMMUNIQUÉ DE PRESSE
Sokoman Minerals Corp. Closes First Tranche of Non-Brokered Flow-Through and Hard-Dollar Private Placement Financing
Sokoman Minerals Corp. announces conditional approval from TSX Venture Exchange for non-brokered Financing, issuing flow-through and non-flow-through shares, and paying cash finders' fees
